Lukl J, Doupal V, Heinc P
First Department of Internal Medicine, University Hospital, Olomouc, Czech Republic.
Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):1844-8. doi: 10.1111/j.1540-8159.1994.tb03760.x.
Twenty-one patients (mean age 68 +/- 8 years) with dual-sensor (QT+activity) DDDR pacemaker were randomly assigned to a crossover, double-blind study in order to evaluate their quality-of-life scores. All pacemakers were implanted for sick sinus syndrome (8 patients) or complete heart block (13 patients). The pacemakers were randomly programmed to VVIR or DDD pacing modes for 2-week periods and then the pacing mode was switched for another 2-week period. At the end of each period, the quality-of-life was evaluated by a questionnaire with regard to cardiovascular symptoms, physical activity, psychosocial and emotional functioning, and self-perceived health. Nineteen questions were scored 0-5 points each. Significant improvement in the mean total quality-of-life score (20.5 +/- 14.9 vs 34.8 +/- 17.4) as well as in dyspnea on effort, dizzy spells, palpitation, sweating, fatigue, lethargy, emotional functioning, and self-perceived health was observed during DDD compared to VVIR pacing. No question was scored in favor of VVIR pacing mode. Significant improvements during DDD pacing was demonstrated in all subgroups of patients (sick sinus syndrome, chronotropically competent and incompetent patients, and patients with high degree AV block). Eighteen patients preferred DDD pacing mode, while only one preferred VVIR pacing mode. Two remaining patients expressed no preference. The results suggest that DDD pacing offers better quality-of-life than dual sensor VVIR pacing in all subgroups of patients commonly indicated for pacemaker implantation.
21例植入双传感器(QT+活动)DDDR起搏器的患者(平均年龄68±8岁)被随机分配至一项交叉双盲研究,以评估其生活质量评分。所有起搏器均因病态窦房结综合征(8例)或完全性心脏传导阻滞(13例)而植入。起搏器被随机程控为VVIR或DDD起搏模式,各持续2周,之后切换起搏模式再持续2周。在每个周期结束时,通过一份关于心血管症状、体力活动、心理社会及情绪功能以及自我感知健康状况的问卷对生活质量进行评估。19个问题每题的评分范围为0至5分。与VVIR起搏相比,在DDD起搏期间,平均总体生活质量评分(20.5±14.9对34.8±17.4)以及劳力性呼吸困难、头晕发作、心悸、出汗、疲劳、嗜睡、情绪功能和自我感知健康状况均有显著改善。没有一个问题的评分支持VVIR起搏模式。在所有患者亚组(病态窦房结综合征、心率适应性正常和异常的患者以及高度房室传导阻滞患者)中,DDD起搏期间均显示出显著改善。18例患者更喜欢DDD起搏模式,而只有1例更喜欢VVIR起搏模式。其余2例患者表示无偏好。结果表明,在通常适合植入起搏器的所有患者亚组中,DDD起搏比双传感器VVIR起搏提供更好的生活质量。